Abstract
Calcium is a ubiquitous second messenger and is involved in virtually all cellular functions. Cellular events being regulated by calcium include gene transcription, metabolism, proliferation and apoptosis. Cancer growth is based on increased proliferation, decreased differentiation and decreased apoptosis. Therefore, the intracellular Ca2+-homeostasis has become one of the focuses in current cancer research. Elevation of the cytoplasmic Ca2+-concentration can result from Ca2+-influx from the extracellular space or from Ca2+-release from intracellular stores. The main intracellular Ca2+-store is the endoplasmic reticulum (ER). The Ca2+-content of the ER is maintained by trans-membrane proteins involving the sarco/endoplasmic reticulum Ca2+-ATPase and the inositol-1,4,5-phosphat receptor. In this review, we summarize the current knowledge of the ER and its trans-membrane proteins as regulating structures of the intracellular Ca2+- homeostasis, what changes occur in malignant cells and how this promotes cancer. We further review possible pharmacological intervention and show future perspectives of the intracellular Ca2+-homeostasis as an anti-cancer target.
Keywords: Cancer, endoplasmic reticulum, calcium, SERCA, IP3R
Anti-Cancer Agents in Medicinal Chemistry
Title: Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer
Volume: 8 Issue: 7
Author(s): A. Bergner and R. M. Huber
Affiliation:
Keywords: Cancer, endoplasmic reticulum, calcium, SERCA, IP3R
Abstract: Calcium is a ubiquitous second messenger and is involved in virtually all cellular functions. Cellular events being regulated by calcium include gene transcription, metabolism, proliferation and apoptosis. Cancer growth is based on increased proliferation, decreased differentiation and decreased apoptosis. Therefore, the intracellular Ca2+-homeostasis has become one of the focuses in current cancer research. Elevation of the cytoplasmic Ca2+-concentration can result from Ca2+-influx from the extracellular space or from Ca2+-release from intracellular stores. The main intracellular Ca2+-store is the endoplasmic reticulum (ER). The Ca2+-content of the ER is maintained by trans-membrane proteins involving the sarco/endoplasmic reticulum Ca2+-ATPase and the inositol-1,4,5-phosphat receptor. In this review, we summarize the current knowledge of the ER and its trans-membrane proteins as regulating structures of the intracellular Ca2+- homeostasis, what changes occur in malignant cells and how this promotes cancer. We further review possible pharmacological intervention and show future perspectives of the intracellular Ca2+-homeostasis as an anti-cancer target.
Export Options
About this article
Cite this article as:
Bergner A. and Huber M. R., Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer, Anti-Cancer Agents in Medicinal Chemistry 2008; 8 (7) . https://dx.doi.org/10.2174/187152008785914734
DOI https://dx.doi.org/10.2174/187152008785914734 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives
Current Topics in Medicinal Chemistry Antitumor Activities of Interleukin-27 on Melanoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Proliferative Role of the Tyrosine Kinase Inhibitors TKI-258 on Oral Squamous Cell Carcinoma In Vitro
Anti-Cancer Agents in Medicinal Chemistry The ARRONAX Project
Current Radiopharmaceuticals Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug Targets Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention
Current Cancer Drug Targets New Pharmacological Perspectives and Therapeutic Potential of PPAR-γ Agonists
Current Pharmaceutical Design Mutant B-Raf Kinase Inhibitors as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies
CNS & Neurological Disorders - Drug Targets Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors
Current Signal Transduction Therapy Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury
Current Molecular Pharmacology Active-Targeted Nanotherapy Strategies for Prostate Cancer
Current Cancer Drug Targets Recents Patents for Isolating, Delivering and Tracking Adult Stem Cells in Regenerative Medicine
Recent Patents on Drug Delivery & Formulation Subject Index to Volume 3
Current Medicinal Chemistry - Central Nervous System Agents Bioremediation of Toxic Heavy Metals: A Patent Review
Recent Patents on Biotechnology Toll-Like Receptors and their Role in Renal Pathologies
Inflammation & Allergy - Drug Targets (Discontinued) Meta Analysis of Advanced Cancer Survival Data Using Lognormal Parametric Fitting: A Statistical Method to Identify Effective Treatment Protocols
Current Pharmaceutical Design Oxygen Sensing, Cardiac Ischemia, HIF-1α and Some Emerging Concepts
Current Cardiology Reviews Preface: [Hot topic: Metal Compounds in Medicinal Chemistry (Executive Editor: Dinorah Gambino)]
Mini-Reviews in Medicinal Chemistry